A detailed history of Washington Trust Advisors, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 50 shares of TECH stock, worth $3,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$3,572
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

SELL
$71.62 - $86.62 $20,196 - $24,426
-282 Reduced 84.94%
50 $3,000
Q4 2022

Feb 08, 2023

SELL
$80.67 - $352.29 $4,598 - $20,080
-57 Reduced 14.65%
332 $27,000
Q3 2022

Oct 14, 2022

SELL
$282.54 - $391.85 $12,149 - $16,849
-43 Reduced 9.95%
389 $110,000
Q2 2022

Jul 25, 2022

BUY
$322.67 - $449.65 $3,872 - $5,395
12 Added 2.86%
432 $150,000
Q1 2022

May 05, 2022

SELL
$353.85 - $487.79 $8,138 - $11,219
-23 Reduced 5.19%
420 $182,000
Q4 2021

Feb 11, 2022

BUY
$456.15 - $525.06 $202,074 - $232,601
443 New
443 $229,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.